These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7290832)

  • 21. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Description of new fibrinolytic enzyme, isolated from the haemolymph of Rhodnius prolixus Stal (Heteroptera Reduviidae).
    Ben Hamouda MH; Soria J; Soria C
    Arch Inst Pasteur Tunis; 1982; 59(2-3):251-68. PubMed ID: 6762857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procoagulant activity in children with community acquired pneumonia, pleural effusion and empyema.
    Michelin E; Snijders D; Conte S; Dalla Via P; Tagliaferro T; Da Dalt L; Monciotti CM; Simioni P; Stefanutti G; Ghirardo V; Gamba P; Barbato A
    Pediatr Pulmonol; 2008 May; 43(5):472-5. PubMed ID: 18383331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an in vitro fibrin clot model to evaluate fibrinolytic agents for wound care application.
    Viennet C; Laurensou C; Goydadin AC; Faivre B; Muret P; Humbert P
    J Wound Care; 2014 Feb; 23(2):66-7, 70, 72. PubMed ID: 24526082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibrinogen and fibrin degradation products: their differentiation.
    Edgington TS
    Thromb Diath Haemorrh; 1975 Dec; 34(3):671-6. PubMed ID: 54944
    [No Abstract]   [Full Text] [Related]  

  • 28. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML; Bang NU
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Level of fibrinogen and fibrinolytic activity of plasma in infants with pneumonia].
    Shaporenko MV
    Pediatr Akus Ginekol; 1970; 5():15-6. PubMed ID: 5504839
    [No Abstract]   [Full Text] [Related]  

  • 31. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemic hemorrhagic fever. The mechanism of coagulation and fibrinolysis.
    Xiang LB; Zhang ZY; Chen JM; Xiang JM; Cosgriff TM
    Chin Med J (Engl); 1990 May; 103(5):391-5. PubMed ID: 1975230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of fibrin-fibrinogen degradation products in gastric aspirate from patients with upper gastrointestinal haemorrhage.
    Lundell L
    Scand J Gastroenterol; 1983 May; 18(3):337-41. PubMed ID: 6608781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between fibrinogen degradation products and cryofibrinogen.
    Komp DM; Donaldson MH
    Am J Pediatr Hematol Oncol; 1979; 1(2):99-102. PubMed ID: 543513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Problems of diagnosis of disseminated intravascular coagulation (DIC).
    Bowie EJ; Owen CA
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Activation of fibrynolysis in children with chronic B or C hepatitis].
    Michalska K; Szaflarska-Popławska A; Dymek G; Kotschy M
    Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo assessment of thrombosis and fibrinolysis during acute myocardial infarction.
    Jaffe AS; Eisenberg PR; Wilner GD
    Prog Hematol; 1987; 15():71-89. PubMed ID: 3332392
    [No Abstract]   [Full Text] [Related]  

  • 39. [The role of fibrinolytic system in pneumonias complicated by exudative pleurisy in children].
    Andreenko GV; Podorol'skaia LV; Fedorov AM
    Vopr Med Khim; 1988; 34(2):110-3. PubMed ID: 3400180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.